Liebman Kilmer Sarah MD is categorized under Internal Medicine Doctors in Concord, NC and active since 2010.
Liebman Kilmer Sarah MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sarah Liebman Kilmer at the company’s single location by writing to 380 Copperfield Boulevard Ne, Concord, North Carolina NC 28025 or by phoning (704) 403-1800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Liebman Kilmer Sarah MD |
| Contact Person: | Sarah Liebman Kilmer |
| Address: | 380 Copperfield Boulevard Ne, Concord, North Carolina 28025 |
| Phone Number: | (704) 403-1800 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Liebman Kilmer Sarah MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Sarah Liebman Kilmer for inquiries that concern Liebman Kilmer Sarah MD by calling the company number (704) 403-1800, as your correspondence is most welcome. Additionally, the physical location of the single location of Liebman Kilmer Sarah MD can be found at the coordinates 35.44806,-80.59632 as well as the street address 380 Copperfield Boulevard Ne in Concord, North Carolina 28025.
For its online presence, you may visit Liebman Kilmer Sarah MD’s website at and engage with its social media outlets through on Twitter and on Facebook.